As of Oct 20
| +0.32 / +0.57%|
The 20 analysts offering 12-month price forecasts for Abbott Laboratories have a median target of 55.50, with a high estimate of 64.00 and a low estimate of 47.00. The median estimate represents a -1.46% decrease from the last price of 56.32.
The current consensus among 24 polled investment analysts is to Buy stock in Abbott Laboratories. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.